4D Molecular Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
/ 
Frequently asked questions
To buy 4D Molecular Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for 4D Molecular Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for 4D Molecular Therapeutics Inc. is FDMT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
4D Molecular Therapeutics Inc. has its primary listing on NASDAQ. You can trade 4D Molecular Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, 4D Molecular Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include 4D Molecular Therapeutics Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like 4D Molecular Therapeutics Inc..